Xu Y - Search Results

1

Targeting PI3Kγ/AKT Pathway Remodels LC3-Associated Phagocytosis Induced Immunosuppression After Radiofrequency Ablation.

Liu X, Zhang W, Xu Y, Xu X, Jiang Q, Ruan J, Wu Y, Zhou Y, Saw PE, Luo B. Liu X, et al. Among authors: xu x, xu y. Adv Sci (Weinh). 2022 Mar;9(7):e2102182. doi: 10.1002/advs.202102182. Epub 2022 Jan 17. Adv Sci (Weinh). 2022. PMID: 35037422 Free PMC article.

2

Assisting anti-PD-1 antibody treatment with a liposomal system capable of recruiting immune cells.

Zhou B , Jiang Q , Xiao X , Xu X , Xu Y , Kong Y , Zhang W , Zeng Y , Liu X , Luo B . Zhou B , et al. Among authors: xu x, xu y. Nanoscale. 2019 Apr 23;11(16):7996-8011. doi: 10.1039/c9nr01434a. Nanoscale. 2019. PMID: 30969294

3

Ultrasound Molecular Imaging as a Potential Non-invasive Diagnosis to Detect the Margin of Hepatocarcinoma via CSF-1R Targeting.

Jiang Q, Zeng Y, Xu Y, Xiao X, Liu H, Zhou B, Kong Y, Saw PE, Luo B. Jiang Q, et al. Among authors: xu y. Front Bioeng Biotechnol. 2020 Jul 14;8:783. doi: 10.3389/fbioe.2020.00783. eCollection 2020. Front Bioeng Biotechnol. 2020. PMID: 32760707 Free PMC article.

4

DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration.

Xu Y, Jiang Q, Liu H, Xiao X, Yang D, Saw PE, Luo B. Xu Y, et al. J Immunol Res. 2020 Dec 30;2020:8835393. doi: 10.1155/2020/8835393. eCollection 2020. J Immunol Res. 2020. PMID: 33490290 Free PMC article.

5

Innovative signature establishment using lymphangiogenesis-related lncRNA pairs to predict prognosis of hepatocellular carcinoma.

Cao J, Xu Y, Liu X, Cai Y, Luo B. Cao J, et al. Among authors: xu y. Heliyon. 2022 Aug 14;8(8):e10215. doi: 10.1016/j.heliyon.2022.e10215. eCollection 2022 Aug. Heliyon. 2022. PMID: 36033263 Free PMC article.

6

HMGB1 released from dead tumor cells after insufficient radiofrequency ablation promotes progression of HCC residual tumor via ERK1/2 pathway.

Zhou Y, Liu X, Zhang W, Xu Y, Zhang Q, Xiong S, Tang H, Luo B. Zhou Y, et al. Among authors: xu y. Int J Hyperthermia. 2023;40(1):2174709. doi: 10.1080/02656736.2023.2174709. Int J Hyperthermia. 2023. PMID: 36755436 Free article.

7

Rho GTPase-activating protein 1 promotes hepatocellular carcinoma progression via modulation by CircPIP5K1A/MiR-101-3p.

Xu Y, Liu X, Cao J, Wu Y, Jiang Q, Luo B. Xu Y, et al. Hepatol Res. 2024 Feb;54(2):174-188. doi: 10.1111/hepr.13972. Epub 2023 Oct 16. Hepatol Res. 2024. PMID: 37792600

8

Nanoparticles (NPs)-mediated Siglec15 silencing and macrophage repolarization for enhanced cancer immunotherapy.

Liu X, Zhang Q, Liang Y, Xiong S, Cai Y, Cao J, Xu Y, Xu X, Wu Y, Lu Q, Xu X, Luo B. Liu X, et al. Among authors: xu x, xu y. Acta Pharm Sin B. 2023 Dec;13(12):5048-5059. doi: 10.1016/j.apsb.2023.07.012. Epub 2023 Jul 17. Acta Pharm Sin B. 2023. PMID: 38045048 Free PMC article.

9

Ligand Effect-Induced Electronic Structure Manipulation of Media-Entropy Alloy for Remarkable Stability over 50,000 Cycles in Oxygen Reduction.

Chen S, Bao D, Zhang L, Xu Y, Peng Y, Liu J, Li T, Zhou X, Yan C, Qian T. Chen S, et al. Among authors: xu y. Inorg Chem. 2024 Nov 19. doi: 10.1021/acs.inorgchem.4c04200. Online ahead of print. Inorg Chem. 2024. PMID: 39561406

10

CHIP away at the marrow-clot connection: inflammation, clonal hematopoiesis, and thromboembolic disease.

Todorovski A, Wang TF, Carrier M, Xu Y. Todorovski A, et al. Among authors: xu y. Blood Adv. 2024 Nov 19:bloodadvances.2024014430. doi: 10.1182/bloodadvances.2024014430. Online ahead of print. Blood Adv. 2024. PMID: 39561373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72,106 results

Search Page

Filters